Extended Medicationplan for Patients with ORal Tumortherapy
Recruiting
- Conditions
- Malignant neoplasms
- Registration Number
- DRKS00016498
- Lead Sponsor
- niversität Bonn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Diagnosis of malignant disease,
Treatment with an oral anticancer drug in the oncologic departments of the University Hospital Cologne,
Age > 18 years,
Sufficient knowledge of German language,
Written consent
Exclusion Criteria
Mental issues or diseases which interfere with cognitive abilities (e.g. Alzheimer´s disease),
Assistance through nursing service or permanent resident in a nursing home,
Intention to change hospital
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility by a standardized questionnaire which is developed during the pilot phase.
- Secondary Outcome Measures
Name Time Method Adherence (Time4Med, MARS-D),<br>Symptom burden (PRO-CTCAE)